Objectives To assess cost-effectiveness of direct oral anticoagulants (DOACs) compared
with vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF) by pooling …

Background Atrial fibrillation (AF) is a severe epidemiological and public health concern
among the elderly population worldwide, with substantial economic and social burdens …

La fibrilación auricular es la arritmia más frecuente. Su clasificación según el patrón y tipo
clínico permiten decidir el tratamiento a emplear que debe incluir control de síntomas y …

Aims Overall, 40% of patients with atrial fibrillation are asymptomatic. The usefulness and
cost-effectiveness of atrial fibrillation screening programmes are debated. We evaluated …

Abstract Background: AF, anticoagulation, NOACs, changing patterns of prescription.
Methods: We describe baseline data and treatment patterns of patients recruited in Belgium …

Introduction Economic evaluations are becoming increasingly important due to limitations in
economic resources, the expense of many new treatments, the need to allocate health …

Background Atrial fibrillation (AF) remains the most common form of cardiac arrhythmia.
Management of AF aims to reduce the risk of stroke, heart failure and premature mortality via …

Abstract Background Novel oral anticoagulants (NOACs) expand the treatment options for
patients with atrial fibrillation (AF). Their benefits need to be weighed against the risk–benefit …

Objective To investigate the predictive performance of machine learning (ML) algorithms for
estimating anticoagulation control in patients with atrial fibrillation (AF) who are treated with …

Objectives. Determine the optimal, licensed, first-line anticoagulant for prevention of
ischemic stroke in patients with non-valvular atrial fibrillation (AF) in England and Wales …